search
Back to results

Rehabilitation Program on Genetic and Degenerative Ataxia (RAPP)

Primary Purpose

Ataxia, Degenerative Disease, Genetic Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
PAMPERO program
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Ataxia focused on measuring Genetic ataxia, Degenerative ataxia, Rehabilitation, Cerebellar ataxia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: ≥ 18 years Patients with genetic and degenerative cerebellar ataxia Diagnostic of cerebellar ataxia confirmed by anatomic MRI Affiliated to a social insurgence regime or similar Patients who have given their free, informed and express consent Walking patients (who can walk unsupervised on flat ground with the help of proper technique : categories greater than 4 on the New Functional Ambulation Classification scale) Non inclusion Criteria: Patients who have already benefited from a hospitalization of more than 3 weeks for rehabilitation during the last 12 months Patients participating simultaneously in another research whose objective would be the evaluation of a therapy, medicinal or not, likely to improve neurological or functional recovery Pregnants, parturient or breastfeeding Patients deprived of their liberty by a judicial or administrative decision Psychiatric care patients Patients admitted to Patients admitted to a health or social establishment for purposes other than research for purposes other than research Major patients protected by the Law

Sites / Locations

  • Service de Rééducation Fonctionnelle (S.S.R.) Val Rosay
  • Service de Rééducation Fonctionnelle (S.S.R.) de l'Hôpital Henry Gabrielle Hospices Civils de Lyon
  • Service de Médecine Physique et Réadaptation (M.P.R) de l'Hôpital Bellevue

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

PAMPERO program group

Usual Care intervention group

Arm Description

This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity.

Usual Rehabilitation of the patient after the inclusion. 0 to 2 physical therapy sessions and 0 to 2 Speech therapy sessions each week usually constitute this program. This rehabilitation highly depends on the patients usual preferences. Some patients have no rehabilitation in the daily care while some have more.

Outcomes

Primary Outcome Measures

Scale for the Assessment and Rating of Ataxia (SARA)
Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA). Scores are from 0 to 42. An higher score is associated with a worse outcome.

Secondary Outcome Measures

Scale for the Assessment and Rating of Ataxia (SARA)
Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA). Scores are from 0 to 42. An higher score is associated with a worse outcome.
Score of the Mini-BESTest scale
Measure of the balance evaluate by Mini-BESTest scale (Mini-Balance Evaluation Systems Test). Scores are from 0 to 28. An higher score is associated with a better outcome.
Eyes open postural surface
Measure of the balance evaluate by the Eyes open postural surface
Displacement length of the center of mass as a function of time eyes open
Measure of the balance evaluated by the displacement length of the center of mass as a function of time eyes open
Scale of Short Falls Efficacy Scale International (Short FES-I)
Fear of fall evaluated by to Scale of Short Falls Efficacy Scale International (Short FES-I). Scores are from 7 to 28. An higher score is associated with a worse outcome.
Number of weekly steps
Number of steps during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC (European Certificate of Conformity)
Time of weekly sedentary activity
Time in minutes/day of sedentary activity during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC
Light, moderate and vigorous weekly activity
Light, moderate and vigorous activity during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC
Short Form Health Survey (SF-36)
Measure of the quality of life evaluate by Short Form Health Survey (SF-36). Scores are from 0 to 100. An higher score is associated with a better outcome.
Number of falls during the study
Risk of falling evaluated by the number of falls during and outside the rehabilitation normalized on 4 weeks
Number of patients who completed the entire PAMPERO program
Number of patients who completed the entire PAMPERO program (5 weeks)
Number of patients who stopped PAMPERO program
Number of patients who stopped PAMPERO program
Time to occurrence of PAMPERO program stops
Time to occurrence of PAMPERO program stops
Reasons of PAMPERO program stops
Reasons of PAMPERO program stops

Full Information

First Posted
October 9, 2023
Last Updated
October 17, 2023
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT06089863
Brief Title
Rehabilitation Program on Genetic and Degenerative Ataxia
Acronym
RAPP
Official Title
Evaluation of the Effect of PAMPERO Rehabilitation Program in Collaboration With Patient Partner on the Symptom Intensity, Activity, and Quality of Life on Genetic and Degenerative Ataxia
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
April 1, 2027 (Anticipated)
Study Completion Date
July 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Cerebellar ataxia is a pathology linked to the lesion of the cerebellum or the afferent and/or efferent cerebellar pathways. The aetiology can be an acquired cerebral lesion, following a chemical poisoning or a genetic degenerative lesion (for example : Friedreich's ataxia, spinocerebellar ataxias, etc.). As reported by the latest estimate available, genetic degenerative cerebellar ataxias affect approximately 6,000 patients in France (Orpha.net). Symptoms suffered by ataxic patients are : problems and gait disorders along with difficulties in coordination resulting in ataxia, uncoordinated movements. These symptoms cause a decrease in the quality of life on patients with spinocerebellar ataxia. The symptoms improvement linked to the cerebellar syndrome is based on rehabilitation that can be supplemented by use of technical aids. Current scientific knowledge confirms that intensive rehabilitation by physiotherapy and occupational therapy in patients with degenerative ataxias improves cerebellar symptoms. Nevertheless, the choice rehabilitation technique stay at the appreciation of the therapist. From the observation, the investigators have designed an intensive multidisciplinary rehabilitation program, called PAMPERO, with partner patients member of two genetic degenerative ataxia patient organisations. This 5-weeks program has been used in clinic during 3 years on 28 patients. It appears to be the only one in France. The preliminary results show a positive effect on ataxia symptom. Nevertheless, the duration of the benefice over time and the effect on the quality of life stay unknown. However, the quality of life is mainly affected by the participation restriction due to the risk of falling. The most frequent complaint from partner patient is the diminution of the social interaction resulting of the incapacity to move without risk. The present protocol aimed at evaluating the Rehabilitation Program in collaboration with partner patient on the symptom intensity, activity and quality of life on genetic and degenerative ataxia. This PAMPERO program's effect will be assessed by comparing the difference of Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA) at inclusion and 3 months after the end of rehabilitation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ataxia, Degenerative Disease, Genetic Disease
Keywords
Genetic ataxia, Degenerative ataxia, Rehabilitation, Cerebellar ataxia

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PAMPERO program group
Arm Type
Experimental
Arm Description
This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity.
Arm Title
Usual Care intervention group
Arm Type
No Intervention
Arm Description
Usual Rehabilitation of the patient after the inclusion. 0 to 2 physical therapy sessions and 0 to 2 Speech therapy sessions each week usually constitute this program. This rehabilitation highly depends on the patients usual preferences. Some patients have no rehabilitation in the daily care while some have more.
Intervention Type
Other
Intervention Name(s)
PAMPERO program
Intervention Description
This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity. The duration of this program is 5 weeks and each week is divided as follow : 5 hours of physical therapy : individual session with the objective to improve the dynamic balance and coordination on the aim to gain confidence of moving, gripping capacity and interaction with object 5 hours of Adapted Physical activity : group session to promote pairing with muscle building priority 1 hour of Speech therapy : group session to educate and promote prevention strategy about dysphagia rick 2 hours of Occupational therapy : group session to bring adaptive solution of autonomy lost with material propose, home organisation or gesture 2 hours of Hydrotherapy : group session activity performed in water to assist rehabilitation
Primary Outcome Measure Information:
Title
Scale for the Assessment and Rating of Ataxia (SARA)
Description
Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA). Scores are from 0 to 42. An higher score is associated with a worse outcome.
Time Frame
Inclusion ; 3 months after the end of rehabilitation
Secondary Outcome Measure Information:
Title
Scale for the Assessment and Rating of Ataxia (SARA)
Description
Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA). Scores are from 0 to 42. An higher score is associated with a worse outcome.
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Score of the Mini-BESTest scale
Description
Measure of the balance evaluate by Mini-BESTest scale (Mini-Balance Evaluation Systems Test). Scores are from 0 to 28. An higher score is associated with a better outcome.
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Eyes open postural surface
Description
Measure of the balance evaluate by the Eyes open postural surface
Time Frame
5 weeks
Title
Displacement length of the center of mass as a function of time eyes open
Description
Measure of the balance evaluated by the displacement length of the center of mass as a function of time eyes open
Time Frame
5 weeks
Title
Scale of Short Falls Efficacy Scale International (Short FES-I)
Description
Fear of fall evaluated by to Scale of Short Falls Efficacy Scale International (Short FES-I). Scores are from 7 to 28. An higher score is associated with a worse outcome.
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Number of weekly steps
Description
Number of steps during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC (European Certificate of Conformity)
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Time of weekly sedentary activity
Description
Time in minutes/day of sedentary activity during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Light, moderate and vigorous weekly activity
Description
Light, moderate and vigorous activity during one week continuously measured by actimeter ActiGraph wGT3X-BT with EUROCOC
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Short Form Health Survey (SF-36)
Description
Measure of the quality of life evaluate by Short Form Health Survey (SF-36). Scores are from 0 to 100. An higher score is associated with a better outcome.
Time Frame
Inclusion ; Immediately or 1 week after the end of rehabilitation ; 3 months after the end of rehabilitation ; 6 months after the end of rehabilitation
Title
Number of falls during the study
Description
Risk of falling evaluated by the number of falls during and outside the rehabilitation normalized on 4 weeks
Time Frame
4 weeks ; up to 3 months ; up to 6 months
Title
Number of patients who completed the entire PAMPERO program
Description
Number of patients who completed the entire PAMPERO program (5 weeks)
Time Frame
5 weeks
Title
Number of patients who stopped PAMPERO program
Description
Number of patients who stopped PAMPERO program
Time Frame
5 weeks
Title
Time to occurrence of PAMPERO program stops
Description
Time to occurrence of PAMPERO program stops
Time Frame
5 weeks
Title
Reasons of PAMPERO program stops
Description
Reasons of PAMPERO program stops
Time Frame
5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥ 18 years Patients with genetic and degenerative cerebellar ataxia Diagnostic of cerebellar ataxia confirmed by anatomic MRI Affiliated to a social insurgence regime or similar Patients who have given their free, informed and express consent Walking patients (who can walk unsupervised on flat ground with the help of proper technique : categories greater than 4 on the New Functional Ambulation Classification scale) Non inclusion Criteria: Patients who have already benefited from a hospitalization of more than 3 weeks for rehabilitation during the last 12 months Patients participating simultaneously in another research whose objective would be the evaluation of a therapy, medicinal or not, likely to improve neurological or functional recovery Pregnants, parturient or breastfeeding Patients deprived of their liberty by a judicial or administrative decision Psychiatric care patients Patients admitted to Patients admitted to a health or social establishment for purposes other than research for purposes other than research Major patients protected by the Law
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lucas PIGNON
Phone
04 78 86 50 58
Ext
+33
Email
lucas.pignon@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Christelle MAROLHO
Phone
04 72 11 57 68
Ext
+33
Email
christelle.marolho@chu-lyon.fr
Facility Information:
Facility Name
Service de Rééducation Fonctionnelle (S.S.R.) Val Rosay
City
Saint-Didier-au-Mont-d'Or
ZIP/Postal Code
69370
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie MD Di Marco
Phone
04 72 53 21 65
Ext
+33
Email
julie.dimarco@ugecam.assurance-maladie.fr
Facility Name
Service de Rééducation Fonctionnelle (S.S.R.) de l'Hôpital Henry Gabrielle Hospices Civils de Lyon
City
Saint-Genis-Laval
ZIP/Postal Code
69230
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lucas PIGNON
Phone
04 78 86 50 58
Ext
+33
Email
lucas.pignon@chu-lyon.fr
Facility Name
Service de Médecine Physique et Réadaptation (M.P.R) de l'Hôpital Bellevue
City
Saint-Étienne
ZIP/Postal Code
42100
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal MD Giraux
Phone
04 77 12 77 57
Ext
+33
Email
pascal.giraux@univ-st-etienne.fr

12. IPD Sharing Statement

Learn more about this trial

Rehabilitation Program on Genetic and Degenerative Ataxia

We'll reach out to this number within 24 hrs